Efficacy of bifidobacterium animalis subsp. lactis (BB-12), b. infantis and lactobacillus acidophilus (La-5) probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial : the PRIMAL clinical study protocol - Marißen, Janina; Haiß, Annette; Meyer, Claudius; Rossum, Thea Van; Bünte, Lisa Marie; Frommhold, David; Gille, Christian; Goedicke-Fritz, Sybelle; Göpel, Wolfgang; Hudalla, Hannes; Pagel, Julia; Pirr, Sabine; et al. (BMJ open, 2019)
Gesehen am 14.10.2020